How To Make More Antidiuretic Drugs Market By Doing Less
The global antidiuretic drugs market size will grow by USD
68.34 million during 2019-2023. The report provides a detailed analysis
of the market by application (autoimmune diseases, urologic diseases,
and other applications) and geography (Asia, Europe, North America, and
ROW). The report analyzes the market’s competitive landscape and offers
information on several antidiuretic drugs manufacturers including
Avadel, CSL Limited, Ferring B.V., Novartis AG, and Sanofi.
The prevalence of chronic conditions that lead to various urologic diseases including polyuria and nocturia, increases with age, and these conditions are prevalent in the geriatric population. The life expectancy of the geriatric population has increased significantly because of rapid developments in healthcare facilities and the availability of advanced treatment options. With the increasing geriatric population and old-age dependency ratio, the incidences of genitourinary conditions will also increase. This will lead to a growing demand for antidiuretic drugs for the treatment of autoimmune and urologic diseases. The rising geriatric population will boost the demand for antidiuretic drugs and drive market growth at a CAGR of almost 10% during the forecast period.
Some of the key findings from our antidiuretic drugs market forecast report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.
Global antidiuretic drugs industry overview
The demand for desmopressin analogs is increasing from healthcare providers and patients because of the high efficacy of its different formulations. Desmopressin is an artificial form of vasopressin hormone which prevents dehydration and controls excess urination (polyuria) and increased thirst (polydipsia). Moreover, the availability of desmopressin analogs in different formulations such as tablets and nasal sprays is further growing its adoption by end-users. The increasing usage of desmopressin analogs is identified as one of the key trends that will gain traction and boost antidiuretic drugs market growth during the next five years.The prevalence of chronic conditions that lead to various urologic diseases including polyuria and nocturia, increases with age, and these conditions are prevalent in the geriatric population. The life expectancy of the geriatric population has increased significantly because of rapid developments in healthcare facilities and the availability of advanced treatment options. With the increasing geriatric population and old-age dependency ratio, the incidences of genitourinary conditions will also increase. This will lead to a growing demand for antidiuretic drugs for the treatment of autoimmune and urologic diseases. The rising geriatric population will boost the demand for antidiuretic drugs and drive market growth at a CAGR of almost 10% during the forecast period.
Comments
Post a Comment